APPLIED PHARMACEUTICAL TOXICOLOGY 2020

May 12 - 14, 2020
Takeda, 35 Landsdowne Street, Cambridge, MA

Lisa Plitnick, PhD

Senior Research Scientist, Merck

Discovery and Development of Vaccines and Worldwide Regulatory Experience

Daniel Nomura, PhD

Professor of Chemical Biology, University of California at Berkeley

Reimagining Druggability using Chemoproteomic Platforms

Kara Pearson, PhD

Director, Analytical and Biochemical Toxicology, Merck

Using Stable Isotope Labeled Tracers to Illuminate Aspects of Hepatic Function and Provide a Translational Biomarker of BSEP Inhibition

Rogely Boyce, Consultant, Beechy Ridge ToxPath, LLC

Brian Enright, Senior Principal Scientist, Preclinical Safety, AbbVie

Juliane Gust, Center for Integrative Brain Research, Seattle Children's Hospital

Tracy Henriques, Toxicologist, AbbVie

Lucas Kempf, Medical Officer Rare Diseases Program, FDA

Lisa Mangus, Assistant Professor, Dept. of Molecular & Comparative Pathobiology, Johns Hopkins School of Medicine

Kim Maratea, Pathology Lead US, AstraZeneca

John McNulty, Director, Shire/Takeda

Scott Mittelstadt, Director, Investigative Toxicology and Safety Pharmacology, AbbVie

Mohan Rao, Computational Toxicologist/Biologist, AbbVie

Chandra Saravanan, Senior Veterinary Pathologist, Novartis Institutes for BioMedical Research

Nicola Stagg, Senior Scientist/Toxicologist, Genentech

Erin Vaughan, Senior Scientist, AbbVie

Francis Wolenski, Senior Toxicologist, Drug Safety Research & Evaluation, Takeda

Sessions for the 2020 Discovery Toxicology Workshop

Session I: IO in Discovery Toxicology Space

Session II: Novel Approaches to Identify Off-Target Drivers of Toxicity

Session III: Case Studies in Investigative Toxicology

Sessions for the 2020 Development Toxicology Workshop

Session IV: Regulatory Hurdles

Session V: Developing Products for Rare Diseases and Conditions

Session VI: Non-Clinical to Clinical Translation - Case Studies

Session VII: Peripheral Neuropathy

Join our LinkedIn Group

Workshops